Sheets Smith Wealth Management Raises Stake in PRA Health Sciences Inc (PRAH)

Sheets Smith Wealth Management lifted its stake in shares of PRA Health Sciences Inc (NASDAQ:PRAH) by 30.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,304 shares of the medical research company’s stock after acquiring an additional 1,914 shares during the period. Sheets Smith Wealth Management’s holdings in PRA Health Sciences were worth $756,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Los Angeles Capital Management & Equity Research Inc. boosted its holdings in PRA Health Sciences by 1.9% during the second quarter. Los Angeles Capital Management & Equity Research Inc. now owns 8,505 shares of the medical research company’s stock worth $638,000 after purchasing an additional 160 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in PRA Health Sciences by 12.0% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,488 shares of the medical research company’s stock worth $112,000 after purchasing an additional 160 shares during the last quarter. Zacks Investment Management boosted its holdings in PRA Health Sciences by 1.3% during the second quarter. Zacks Investment Management now owns 48,885 shares of the medical research company’s stock worth $3,667,000 after purchasing an additional 614 shares during the last quarter. Carroll Financial Associates Inc. boosted its holdings in PRA Health Sciences by 127.4% during the third quarter. Carroll Financial Associates Inc. now owns 1,410 shares of the medical research company’s stock worth $112,000 after purchasing an additional 790 shares during the last quarter. Finally, Ameritas Investment Partners Inc. boosted its holdings in PRA Health Sciences by 23.5% during the third quarter. Ameritas Investment Partners Inc. now owns 4,204 shares of the medical research company’s stock worth $325,000 after purchasing an additional 800 shares during the last quarter. Institutional investors and hedge funds own 98.22% of the company’s stock.

Several brokerages recently commented on PRAH. Zacks Investment Research upgraded shares of PRA Health Sciences from a “hold” rating to a “buy” rating and set a $103.00 target price for the company in a report on Thursday. Mizuho began coverage on shares of PRA Health Sciences in a report on Thursday, September 21st. They set a “buy” rating and a $82.00 target price for the company. BidaskClub cut shares of PRA Health Sciences from a “strong-buy” rating to a “buy” rating in a report on Friday, January 5th. Robert W. Baird restated a “buy” rating and set a $88.00 target price on shares of PRA Health Sciences in a report on Monday, October 9th. Finally, KeyCorp restated a “buy” rating and set a $93.00 target price (up previously from $86.00) on shares of PRA Health Sciences in a report on Monday, October 30th. One analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. PRA Health Sciences currently has a consensus rating of “Buy” and an average target price of $92.00.

In other PRA Health Sciences news, insider David W. Dockhorn sold 72,850 shares of the stock in a transaction on Thursday, December 28th. The shares were sold at an average price of $90.83, for a total value of $6,616,965.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Matthew P. Young sold 5,115 shares of the stock in a transaction on Thursday, November 16th. The shares were sold at an average price of $79.90, for a total transaction of $408,688.50. The disclosure for this sale can be found here. In the last quarter, insiders sold 150,815 shares of company stock valued at $13,642,620. Corporate insiders own 2.10% of the company’s stock.

Shares of PRA Health Sciences Inc (NASDAQ:PRAH) opened at $90.06 on Friday. The company has a market cap of $5,788.19, a price-to-earnings ratio of 50.31, a price-to-earnings-growth ratio of 1.28 and a beta of 0.41. The company has a debt-to-equity ratio of 1.38, a current ratio of 1.01 and a quick ratio of 1.01. PRA Health Sciences Inc has a 12 month low of $54.08 and a 12 month high of $92.84.

PRA Health Sciences (NASDAQ:PRAH) last announced its quarterly earnings results on Wednesday, October 25th. The medical research company reported $0.88 EPS for the quarter, beating analysts’ consensus estimates of $0.85 by $0.03. The firm had revenue of $494.55 million during the quarter, compared to analysts’ expectations of $477.89 million. PRA Health Sciences had a net margin of 5.64% and a return on equity of 21.66%. The company’s revenue for the quarter was up 23.7% compared to the same quarter last year. During the same quarter last year, the company posted $0.64 earnings per share. equities research analysts expect that PRA Health Sciences Inc will post 3.2 EPS for the current year.

WARNING: “Sheets Smith Wealth Management Raises Stake in PRA Health Sciences Inc (PRAH)” was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this report on another publication, it was copied illegally and republished in violation of United States and international trademark and copyright laws. The legal version of this report can be viewed at https://www.dispatchtribunal.com/2018/01/13/sheets-smith-wealth-management-raises-stake-in-pra-health-sciences-inc-prah.html.

About PRA Health Sciences

PRA Health Sciences, Inc is a contract research organization. The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company offers therapeutic services in areas of pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases.

Want to see what other hedge funds are holding PRAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PRA Health Sciences Inc (NASDAQ:PRAH).

Institutional Ownership by Quarter for PRA Health Sciences (NASDAQ:PRAH)

Receive News & Ratings for PRA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PRA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply